Skip to content

Georgia · Nonprofit

Augusta Biomedical Research Corporation

Augusta Biomedical Research Corporation (Georgia) receives grants from 1 organization whose IRS filings report $13,000 to it, the largest being AMERICAN LEGION DEPARTMENT OF GEORGIA ($13,000). 0 of them have funded it in more than one year.

Revenue FY2025
$181k
Funders on record
1
Grants received
$13k
Net assets
$189k
0/1 repeat funderspeak grant-dependency 4%
01What it does

What Augusta Biomedical Research Corporation does

Mission

To advance the research and education missions of the Department of Veterans Affairs (VA), and specifically the Charlie Norwood VA Medical Center, Augusta, GA, through the support of research-related and education-related activities.

As stated on its FY2025 Form 990.

Program

  1. Research Administration ABRC provided grant application submission and contract negotiation services for investigators. ABRC provided fiscal oversight to include administration of the project funds, monitoring budgets, and creating timely financial reports. ABRC administers 35 accounts for 19 members conducting active research in the following research areas: cardiology, neurology, dermatology, urology, geriatrics, prostate cancer, ophthalmology and oncology. Human Resources Administration ABRC hires research staff directly or reimburses another employer for their employees' time spent working on VA approved research studies. When ABRC hires employees, it provides payroll services including direct deposit, state and federal tax filing, unemployment insurance, and leave tracking. When another employer is reimbursed, ABRC provides bookkeeping services to handle invoices and payments.

    $119,412 spent
    100% of program spending

The program described on its FY2025 Form 990. Program spending in total: $119,412.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended.

100 = 20172017 Revenue 100 ($475k) Expenses 100 ($463k) Net assets 100 ($472k)2018 Revenue 95 ($453k) Expenses 89 ($410k) Net assets 109 ($515k)2019 Revenue 63 ($298k) Expenses 78 ($360k) Net assets 96 ($454k)2020 Revenue 21 ($102k) Expenses 37 ($170k) Net assets 82 ($385k)2021 Revenue 22 ($102k) Expenses 29 ($135k) Net assets 75 ($353k)2022 Revenue 17 ($80k) Expenses 33 ($153k) Net assets 59 ($280k)2023 Revenue 73 ($346k) Expenses 77 ($356k) Net assets 61 ($287k)2024 Revenue 61 ($289k) Expenses 71 ($327k) Net assets 53 ($249k)2025 Revenue 38 ($181k) Expenses 53 ($245k) Net assets 40 ($189k)
'17'18'19'20'21'22'23'24'25
Revenue (38)Expenses (53)Net assets (40)

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $348k to $261k (−25%).

$486k
$529k
$475k
$407k
$375k
$304k
$348k
$261k
$198k
'17'18'19'20'21'22'23'24'25
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
2025
ContributionsProgram revenueInvestmentOther

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 7 of the last 9 reported years ran a deficit.

$12k
’17
$43k
’18
−$62k
’19
−$68k
’20
−$33k
’21
−$73k
’22
−$10k
’23
−$38k
’24
−$63k
’25
9.1
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Board chair

Amado Baez MD

Board Chair

As listed on its FY2025 Form 990.

'17'18'19'20'21'22'23'24'25
Listed966656666
Joined·+0+1+0+0+3+1+0+3
No longer listed·31012103
03Who funds it

Who funds it, year by year

Grant support over time, funder by funder — shade shows the grant size each year.

Funder
'19
total
funders
1

From the IRS filings of Augusta Biomedical Research Corporation’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

100% of Augusta Biomedical Research Corporation's grant income comes from Georgia funders.

GA

Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Government funding Augusta Biomedical Research Corporation receives

Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $299k on record.

Federal$299k
grants $299kcontracts $0
Top agencies
  • Department of Health and Human Services$299k

Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.

Organizations like Augusta Biomedical Research Corporation

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Georgia

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

49% of spending goes to programs.

Program 49%Management 51%Fundraising 0%

Governance

6
board members
100%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990–Audited financials

Footprint & structure

Files a return copy in 1 state

GA

Screen this organization

A dated, signed PDF of the compliance screen for Augusta Biomedical Research Corporation: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds Augusta Biomedical Research Corporation?
Augusta Biomedical Research Corporation (Georgia) receives grants from 1 organization whose IRS filings report $13,000 to it, the largest being AMERICAN LEGION DEPARTMENT OF GEORGIA ($13,000). 0 of them have funded it in more than one year.
How many funders does Augusta Biomedical Research Corporation have?
IRS filings report 1 organization giving $13,000 in grants to Augusta Biomedical Research Corporation.
Who is the largest funder of Augusta Biomedical Research Corporation?
AMERICAN LEGION DEPARTMENT OF GEORGIA is the largest funder on record, with $13,000 in grants. The full list of funders is on this page.
How can an organization like Augusta Biomedical Research Corporation find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Georgia. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

Play a game about who funds Augusta Biomedical Research →

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 1 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing